These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 16724455)
1. FR220897 and FR220899, novel antifungal lipopeptides from Coleophoma empetri no. 14573. Kanasaki R; Abe F; Kobayashi M; Katsuoka M; Hashimoto M; Takase S; Tsurumi Y; Fujie A; Hino M; Hashimoto S; Hori Y J Antibiot (Tokyo); 2006 Mar; 59(3):149-57. PubMed ID: 16724455 [TBL] [Abstract][Full Text] [Related]
2. FR227673 and FR190293, novel antifungal lipopeptides from Chalara sp. No. 22210 and tolypocladium parasiticum No. 16616. Kanasaki R; Kobayashi M; Fujine K; Sato I; Hashimoto M; Takase S; Tsurumi Y; Fujie A; Hino M; Hashimoto S; Hori Y J Antibiot (Tokyo); 2006 Mar; 59(3):158-67. PubMed ID: 16724456 [TBL] [Abstract][Full Text] [Related]
3. FR209602 and related compounds, novel antifungal lipopeptides from Coleophoma crateriformis no.738. I. Taxonomy, fermentation, isolation and physico-chemical properties. Kanasaki R; Sakamoto K; Hashimoto M; Takase S; Tsurumi Y; Fujie A; Hino M; Hashimoto S; Hori Y J Antibiot (Tokyo); 2006 Mar; 59(3):137-44. PubMed ID: 16724453 [TBL] [Abstract][Full Text] [Related]
4. FR209602 and related compounds, novel antifungal lipopeptides from coleophoma crateriformis no. 738. II. In vitro and in vivo antifungal activity. Kanasaki R; Abe F; Furukawa S; Yoshikawa K; Fujie A; Hino M; Hashimoto S; Hori Y J Antibiot (Tokyo); 2006 Mar; 59(3):145-8. PubMed ID: 16724454 [TBL] [Abstract][Full Text] [Related]
5. WF11899A, B and C, novel antifungal lipopeptides. I. Taxonomy, fermentation, isolation and physico-chemical properties. Iwamoto T; Fujie A; Sakamoto K; Tsurumi Y; Shigematsu N; Yamashita M; Hashimoto S; Okuhara M; Kohsaka M J Antibiot (Tokyo); 1994 Oct; 47(10):1084-91. PubMed ID: 7961156 [TBL] [Abstract][Full Text] [Related]
6. [Antifungal activity and clinical efficacy of micafungin (funguard)]. Ikeda F Nihon Ishinkin Gakkai Zasshi; 2005; 46(4):217-22. PubMed ID: 16282962 [TBL] [Abstract][Full Text] [Related]
7. Cyclic tripeptides from the halotolerant fungus Aspergillus sclerotiorum PT06-1. Zheng J; Xu Z; Wang Y; Hong K; Liu P; Zhu W J Nat Prod; 2010 Jun; 73(6):1133-7. PubMed ID: 20503985 [TBL] [Abstract][Full Text] [Related]
8. Hassallidin A, a glycosylated lipopeptide with antifungal activity from the cyanobacterium Hassallia sp. Neuhof T; Schmieder P; Preussel K; Dieckmann R; Pham H; Bartl F; von Döhren H J Nat Prod; 2005 May; 68(5):695-700. PubMed ID: 15921412 [TBL] [Abstract][Full Text] [Related]
9. Acquired resistance to echinocandins in Candida albicans: case report and review. Baixench MT; Aoun N; Desnos-Ollivier M; Garcia-Hermoso D; Bretagne S; Ramires S; Piketty C; Dannaoui E J Antimicrob Chemother; 2007 Jun; 59(6):1076-83. PubMed ID: 17468115 [TBL] [Abstract][Full Text] [Related]
10. Conjugation of fatty acids with different lengths modulates the antibacterial and antifungal activity of a cationic biologically inactive peptide. Malina A; Shai Y Biochem J; 2005 Sep; 390(Pt 3):695-702. PubMed ID: 15907192 [TBL] [Abstract][Full Text] [Related]
11. Arborcandins A, B, C, D, E and F, novel 1,3-beta-glucan synthase inhibitors: production and biological activity. Ohyama T; Kurihara Y; Ono Y; Ishikawa T; Miyakoshi S; Hamano K; Arai M; Suzuki T; Igari H; Suzuki Y; Inukai M J Antibiot (Tokyo); 2000 Oct; 53(10):1108-16. PubMed ID: 11132955 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of FK463, a (1,3)-beta-D-glucan synthase inhibitor, in disseminated azole-resistant candida albicans infection in mice. Maesaki S; Hossain MA; Miyazaki Y; Tomono K; Tashiro T; Kohno S Antimicrob Agents Chemother; 2000 Jun; 44(6):1728-30. PubMed ID: 10817741 [TBL] [Abstract][Full Text] [Related]
13. Rhodopeptins (Mer-N1033), novel cyclic tetrapeptides with antifungal activity from Rhodococcus sp. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activities. Chiba H; Agematu H; Kaneto R; Terasawa T; Sakai K; Dobashi K; Yoshioka T J Antibiot (Tokyo); 1999 Aug; 52(8):695-9. PubMed ID: 10580382 [TBL] [Abstract][Full Text] [Related]
14. Fungal biofilm inhibitors from a human oral microbiome-derived bacterium. Wang X; Du L; You J; King JB; Cichewicz RH Org Biomol Chem; 2012 Mar; 10(10):2044-50. PubMed ID: 22281750 [TBL] [Abstract][Full Text] [Related]
15. Mannich reaction: an approach for the synthesis of water soluble mulundocandin analogues. Lal B; Gund VG; Bhise NB; Gangopadhyay AK Bioorg Med Chem; 2004 Apr; 12(7):1751-68. PubMed ID: 15028266 [TBL] [Abstract][Full Text] [Related]
16. Approaches towards the stabilization of hemiaminal function at ornithine unit of mulundocandin. Lal B; Gund VG Bioorg Med Chem Lett; 2004 Mar; 14(5):1123-8. PubMed ID: 14980649 [TBL] [Abstract][Full Text] [Related]
17. FR901469, a novel antifungal antibiotic from an unidentified fungus No.11243. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological properties. Fujie A; Iwamoto T; Muramatsu H; Okudaira T; Nitta K; Nakanishi T; Sakamoto K; Hori Y; Hino M; Hashimoto S; Okuhara M J Antibiot (Tokyo); 2000 Sep; 53(9):912-9. PubMed ID: 11099224 [TBL] [Abstract][Full Text] [Related]
18. Balticidins A-D, antifungal hassallidin-like lipopeptides from the Baltic Sea cyanobacterium Anabaena cylindrica Bio33. Bui TH; Wray V; Nimtz M; Fossen T; Preisitsch M; Schröder G; Wende K; Heiden SE; Mundt S J Nat Prod; 2014 Jun; 77(6):1287-96. PubMed ID: 24937366 [TBL] [Abstract][Full Text] [Related]
19. Purification of antifungal lipopeptides by reversed-phase high-performance liquid chromatography. Razafindralambo H; Paquot M; Hbid C; Jacques P; Destain J; Thonart P J Chromatogr; 1993 Jun; 639(1):81-5. PubMed ID: 8331146 [TBL] [Abstract][Full Text] [Related]
20. Isolation and structural elucidation of proline-containing cyclopentapeptides from an endolichenic Xylaria sp. Wu W; Dai H; Bao L; Ren B; Lu J; Luo Y; Guo L; Zhang L; Liu H J Nat Prod; 2011 May; 74(5):1303-8. PubMed ID: 21428374 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]